Literature DB >> 21399947

Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study.

Hirotoshi Kobayashi1, Hidetaka Mochizuki, Tomoyuki Kato, Takeo Mori, Shingo Kameoka, Kazuo Shirouzu, Yukio Saito, Masahiko Watanabe, Takayuki Morita, Jin-Ichi Hida, Masashi Ueno, Masato Ono, Masamichi Yasuno, Kenichi Sugihara.   

Abstract

PURPOSE: The present study aims to define the prognostic impact of the lymph node ratio (LNR) in patients with stage III distal rectal cancer.
METHODS: We analyzed data from 501 patients who underwent curative resection (total mesorectal excision, TME) for stage III distal rectal cancer at 12 institutions between 1991 and 1998. Patients were divided into four groups according to quartiles based on LNR.
RESULTS: Among the 501 patients, 381 underwent TME with pelvic sidewall dissection (PSD). The median numbers of lymph nodes retrieved with and without PSD were 45 and 17, respectively (P < 0.0001). Forty-nine patients with lymph node retrieved less than 12 were excluded from further analyses. Among various clinicopathological parameters, univariate analysis identified age (P = 0.0059), histological grade (P < 0.0001), depth of tumor invasion (P = 0.0003), and number of positive nodes (P < 0.0001) and LNR (P < 0.0001) as prognostic factors. The Cox proportional hazards model revealed that age (P = 0.014), histological grade (P < 0.0001), depth of tumor invasion (P = 0.0002), and LNR (group 3, P = 0.0012; group 4, P < 0.0001) were independent prognostic factors. When the American Joint Committee on Cancer (AJCC) seventh staging system was added as a covariate, both AJCC stage (P < 0.0001) and LNR (P < 0.0001) were independent prognostic factors.
CONCLUSIONS: Adding the LNR concept to the AJCC cancer staging system will improve accuracy in evaluating the nodal status of distal rectal cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21399947     DOI: 10.1007/s00384-011-1173-0

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  29 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Indication and benefit of pelvic sidewall dissection for rectal cancer.

Authors:  Kenichi Sugihara; Hirotoshi Kobayashi; Tomoyuki Kato; Takeo Mori; Hidetaka Mochizuki; Shingo Kameoka; Kazuo Shirouzu; Tetsuichiro Muto
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

3.  Effect of high and intermediate ligation on survival and recurrence rates following curative resection of colorectal cancer.

Authors:  C A Slanetz; R Grimson
Journal:  Dis Colon Rectum       Date:  1997-10       Impact factor: 4.585

4.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

5.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

Authors:  Robert Rosenberg; Jan Friederichs; Tibor Schuster; Ralf Gertler; Matthias Maak; Karen Becker; Anne Grebner; Kurt Ulm; Heinz Höfler; Hjalmar Nekarda; Jörg-Rüdiger Siewert
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

6.  The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.

Authors:  Frédérique Peschaud; Peschaud Frédérique; Stéphane Benoist; Benoist Stéphane; Catherine Julié; Julié Catherine; Alain Beauchet; Beauchet Alain; Christophe Penna; Penna Christophe; Philippe Rougier; Rougier Philippe; Bernard Nordlinger
Journal:  Ann Surg       Date:  2008-12       Impact factor: 12.969

7.  Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.

Authors:  Hirotoshi Kobayashi; Hidetaka Mochizuki; Tomoyuki Kato; Takeo Mori; Shingo Kameoka; Kazuo Shirouzu; Kenichi Sugihara
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

8.  Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer.

Authors:  Chih-Chien Chin; Jeng-Yi Wang; Chien-Yuh Yeh; Yi-Hung Kuo; Wen-Shih Huang; Chung-Hung Yeh
Journal:  Int J Colorectal Dis       Date:  2009-05-29       Impact factor: 2.571

9.  Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan.

Authors:  Kenjiro Kotake; Satoshi Honjo; Kenichi Sugihara; Tomoyuki Kato; Susumu Kodaira; Takashi Takahashi; Masayuki Yasutomi; Tetsuichiro Muto; Yasuo Koyama
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

10.  The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?

Authors:  R J Heald; E M Husband; R D Ryall
Journal:  Br J Surg       Date:  1982-10       Impact factor: 6.939

View more
  11 in total

Review 1.  Restaging of colorectal cancer and PET/CT.

Authors:  Alev Çınar; Esra Arzu Gençoğlu; Meliha Korkmaz
Journal:  Ulus Cerrahi Derg       Date:  2013-06-01

2.  Prognostic and survival analysis of 837 Chinese colorectal cancer patients.

Authors:  Ying Yuan; Mo-Dan Li; Han-Guang Hu; Cai-Xia Dong; Jia-Qi Chen; Xiao-Fen Li; Jing-Jing Li; Hong Shen
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

3.  The prognostic value of lymph node ratio and updated TNM classification in rectal cancer patients with adequate versus inadequate lymph node dissection.

Authors:  T Junginger; U Goenner; A Lollert; D Hollemann; M Berres; M Blettner
Journal:  Tech Coloproctol       Date:  2014-03-19       Impact factor: 3.781

4.  Log odds of positive lymph nodes is superior to the number- and ratio-based lymph node classification systems for colorectal cancer patients undergoing curative (R0) resection.

Authors:  Hong Yan Fang; Hui Yang; Zhong Shi He; Hong Zhao; Zhen Ming Fu; Fu Xiang Zhou; Yun Feng Zhou
Journal:  Mol Clin Oncol       Date:  2017-03-22

Review 5.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

6.  Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer.

Authors:  Ryota Nakanishi; Jun Harada; Munkhbold Tuul; Yan Zhao; Koji Ando; Hiroshi Saeki; Eiji Oki; Takefumi Ohga; Hiroyuki Kitao; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2012-11-29       Impact factor: 3.402

7.  Prognostic Significance of Lymph Node Ratio in Stage III Rectal Cancer.

Authors:  Jin Yong Shin; Kwan Hee Hong
Journal:  J Korean Soc Coloproctol       Date:  2011-10-31

8.  Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis.

Authors:  Ming-Ran Zhang; Tian-Hang Xie; Jun-Lin Chi; Yuan Li; Lie Yang; Yong-Yang Yu; Xiao-Feng Sun; Zong-Guang Zhou
Journal:  Oncotarget       Date:  2016-11-08

9.  Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer.

Authors:  Wafi Attaallah; Omer Gunal; Manuk Manukyan; Gulden Ozden; Cumhur Yegen
Journal:  Ann Coloproctol       Date:  2013-06-30

10.  The number of metastatic lymph nodes exhibiting poorly differentiated clusters predicts survival in patients with pStage III colorectal cancer.

Authors:  Osamu Kinoshita; Mitsuo Kishimoto; Yasutoshi Murayama; Yoshiaki Kuriu; Masayoshi Nakanishi; Chohei Sakakura; Eigo Otsuji; Akio Yanagisawa
Journal:  Int J Colorectal Dis       Date:  2015-09-28       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.